|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Aug―13 |
COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation |
Lanting Yang, Shangbin Tang, Jingchuan Guo, Nico Gabriel, Walid F. Gellad, Utibe R. Essien, Jared W. Magnani, Inmaculada Hernandez |
2 |
[GO] |
2022―Aug―25 |
Remdesivir-induced Bradycardia is not Associated with Worse Outcome in Patients with COVID-19: A Retrospective Analysis |
Ioannis Pantazopoulos, Georgios Mavrovounis, Georgios Dimeas, Nikolaos Zikos, Maria Pitsikou, Eleni Rousogianni, Maria Mermiri, Anastasia Michou, Michalis Spanos, Christos Maniotis, Athanasios Chalkias, Eleni Laou, Georgios Zakynthinos, Dimitrios Chatzis, Konstantinos Gourgoulianis |
3 |
[GO] |
2021―Dec―21 |
Correction to: Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis |
Adrija Hajra, Manasvi Gupta, Binita Ghosh, Kumar Ashish, Neelkumar Patel, Gaurav Manek, Devesh Rai, Jayakumar Sreenivasan, Akshay Goel, Carl J. Lavie, Dhrubajyoti Bandyopadhyay |
4 |
[GO] |
2021―Nov―24 |
Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis |
Adrija Hajra, Manasvi Gupta, Binita Ghosh, Kumar Ashish, Neelkumar Patel, Gaurav Manek, Devesh Rai, Dhrubajyoti Bandyopadhyay, Carl J. Lavie |
5 |
[GO] |
2021―Aug―03 |
The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis |
Chia Siang Kow, Syed Shahzad Hasan |
6 |
[GO] |
2021―Mar―26 |
Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries |
Inmaculada Hernandez, Mina Tadrous, Jared W. Magnani, Jingchuan Guo, Katie J. Suda |
7 |
[GO] |
2021―Mar―22 |
Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione |
Wayne Kaesemeyer, Tatsiana Suvorava |
8 |
[GO] |
2020―Nov―03 |
Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology |
Giuseppe Patti, Veronica Lio, Ilaria Cavallari, Felice Gragnano, Letizia Riva, Paolo Calabrò, Giuseppe Di Pasquale, Vittorio Pengo, Andrea Rubboli |
9 |
[GO] |
2020―Sep―12 |
Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis |
Syed Shahzad Hasan, Chia Siang Kow, Muhammad Abdul Hadi, Syed Tabish Razi Zaidi, Hamid A. Merchant |
10 |
[GO] |
2020―Sep―12 |
Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections |
Rami A. Al-Horani |
11 |
[GO] |
2020―Aug―04 |
Current Overview on Hypercoagulability in COVID-19 |
Namrata Singhania, Saurabh Bansal, Divya P. Nimmatoori, Abutaleb A. Ejaz, Peter A. McCullough, Girish Singhania |
12 |
[GO] |
2020―Aug―01 |
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection? |
Fabian Sanchis-Gomar, Carl J. Lavie, Daniel P. Morin, Carme Perez-Quilis, Jari A. Laukkanen, Marco V. Perez |
13 |
[GO] |
2020―Jun―23 |
COVID-19 Pandemic: Cardiovascular Complications and Future Implications |
Dhrubajyoti Bandyopadhyay, Tauseef Akhtar, Adrija Hajra, Manasvi Gupta, Avash Das, Sandipan Chakraborty, Ipsita Pal, Neelkumar Patel, Birendra Amgai, Raktim K. Ghosh, Gregg C. Fonarow, Carl J. Lavie, Srihari S. Naidu |
14 |
[GO] |
2020―May―26 |
Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide |
Chia Siang Kow, Wendy Sunter, Amie Bain, Syed Tabish Razi Zaidi, Syed Shahzad Hasan |
15 |
[GO] |
2020―Apr―13 |
Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19 |
Chia Siang Kow, Syed Tabish Razi Zaidi, Syed Shahzad Hasan |